Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21618437 | 0.94 | CES2 (0.55) | CES2TSHRCYP3A4MAPTPLA2G4B | |
| SCHEMBL6882009 | 0.92 | CES2 (0.58) | CES2TSHRCYP3A4MAPTPLA2G4B | |
| Acrylic Acid SCHEMBL6547641 | 0.90 | TSHR (0.43) | CES2TSHRALDH1A1HPGDATM | |
| SCHEMBL5068236 | 0.88 | CES2 (0.36) | CES2TSHR | |
| SCHEMBL9637985 | 0.82 | TSHR (0.48) | CES2TSHRALDH1A1HPGDATM | |
| SCHEMBL28833990 | 0.82 | TSHR (0.43) | CES2TSHRALDH1A1HPGDATM | |
| SCHEMBL2786442 | 0.82 | CES2 (0.48) | CES2TSHRALDH1A1HPGDATM | |
| Urea SCHEMBL28059895 | 0.81 | TSHR (0.54) | CES2TSHRALDH1A1HPGDATM | |
| SCHEMBL1478517 | 0.81 | — | — | |
| Urea SCHEMBL8373138 | 0.80 | TSHR (0.59) | CES2TSHRALDH1A1HPGDATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1620 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071989-A1 | SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA | UNIV PUERTO RICO (US) | 2026-03-12 | — | — | US | claimed |
| US-12573635-B2 | Anode slurry composition for secondary battery | HANSOL CHEMICAL CO., LTD. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20260011732-A1 | ON-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO. LTD. (KR) | 2026-01-08 | — | — | US | claimed |
| WO-2025226965-A1 | ALGICIDAL FOAM COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2025-10-30 | — | — | WO | claimed |
| EP-4019560-B1 | ION CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO LTD (KR) | 2025-10-29 | — | — | EP | claimed |
| US-20250300179-A1 | ION-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO LTD (KR) | 2025-09-25 | — | — | US | claimed |
| WO-2025105585-A1 | BINDER, METHOD FOR MANUFACTURING SAME, ELECTRODE COMPRISING SAME, SECONDARY BATTERY COMPRISING SAME, AND CAPACITOR COMPRISING SAME | (주)에코케미칼 | 2025-05-22 | — | — | WO | claimed |
| US-12295353-B2 | L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders | THE INSTITUTE FOR ETHNOMEDICINE (US) | 2025-05-13 | — | — | US | claimed |
| US-20250140857-A1 | ION-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO., LTD. (KR) | 2025-05-01 | — | — | US | claimed |
| CN-119753874-A | Luminous anchor net material suitable for stress and preparation method thereof | 中煤科工开采研究院有限公司 | 2025-04-04 | — | — | CN | claimed |
| EP-0361048-A1 | Curable composition containing a Michael addition product, its preparation and its use | BASF Lacke + Farben AG (DE) | 1990-04-04 | — | — | EP | claimed |
| EP-0342205-A1 | HARDENABLE COMPOSITION ON THE BASIS OF A MICHAEL ADDITION PRODUCT, PROCESS FOR THE MANUFACTURE THEREOF AND USE THEREOF | BASF Lacke + Farben AG (DE) | 1989-11-23 | — | — | EP | claimed |
| EP-0287842-A1 | Curable compositions containing a Michael-addition product, their preparation and use | BASF Lacke + Farben AG (DE) | 1988-10-26 | — | — | EP | claimed |
| WO-1988007556-A1 | HARDENABLE COMPOSITION ON THE BASIS OF A MICHAEL ADDITION PRODUCT, PROCESS FOR THE MANUFACTURE THEREOF AND USE THEREOF | BASF LACKE + FARBEN AKTIENGESELLSCHAFT (DE) | 1988-10-06 | — | — | WO | claimed |
| EP-0268296-A2 | Membrane affinity concentration immunoassay | GENETIC SYSTEMS CORPORATION (US) | 1988-05-25 | — | — | EP | claimed |
| US-4031290-A | ALPHA-BETA MONOMERS, CATALYSIS | PPG INDUSTRIES, INC. (US) | 1977-06-21 | — | — | US | claimed |
| US-4021396-A | INTERIORS AND EXTERIORS OF CANS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-05-03 | — | — | US | claimed |
| US-4016332-A | OF ETHYLENICALLY UNSATURATED MONOMERS | PPG INDUSTRIES, INC. (US) | 1977-04-05 | — | — | US | claimed |
| US-3997694-A | Container coated with a ductile coating of an acrylic polymer having reactive sites and an epoxy resin | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-12-14 | — | — | US | claimed |
| US-3943187-A | Ductile coating composition of an acrylic polymer having reactive sites and an epoxy resin | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-03-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071989-A1 | SINGLE-STRANDED DNA MOLECULAR RECOGNITION ELEMENTS AGAINST CYANOTOXIN L-BMAA | MB, BLM, ADA | CES2 3556/4885TSHR 3072/4885ALDH1A1 4012/4885 |
| US-20260011732-A1 | ON-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SCN10A, SCN11A, KCNK10 | CES2 1143/4885TSHR 2631/4885ALDH1A1 1132/4885 |
| US-12573635-B2 | Anode slurry composition for secondary battery | CYBB, ADCY10, AK2 | CES2 1462/4885TSHR 3842/4885ALDH1A1 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.